Moreover, the MTAP‐ and PRMT5‐mediated sDMA modification negatively regulates the stability of vimentin protein via proteasomal degradation, as evidenced by the observations from two independent cohorts, Taiwan Cancer Moonshot proteogenomic data and tissue microarray IHC staining data. The gene discussed is PRMT5; the disease is cancer.